Company Filing History:
Years Active: 2014
Title: Richard Raymond Schartman: A Pioneer in Pharmaceutical Innovations
Introduction
Richard Raymond Schartman, based in Wallingford, Connecticut, is an accomplished inventor known for his contributions to the pharmaceutical industry. He holds a patent that demonstrates his innovative approach to addressing significant health issues, particularly in the realm of migraine treatment and other related disorders.
Latest Patents
Schartman's key patent involves a hemisulfate salt of a specific compound, which is disclosed alongside crystalline forms of the salt. The patent outlines methods for utilizing this compound as a CGRP receptor antagonist. This advancement plays a crucial role in creating pharmaceutical compositions aimed at treating and preventing migraines, neurogenic vasodilation, and other disorders such as asthma and chronic obstructive pulmonary disease (COPD), among others.
Career Highlights
Richard Raymond Schartman has made significant strides in his career, contributing valuable innovations while working for Bristol-Myers Squibb Company. His expertise in pharmaceutical sciences has led to the development of techniques that can have impactful applications in treating various medical conditions.
Collaborations
Throughout his career, Schartman has collaborated with distinguished colleagues, including Daniel Richard Roberts and Chenkou Wei. Together, they have worked on various projects within the pharmaceutical field, further enhancing the scope of their innovations.
Conclusion
Richard Raymond Schartman exemplifies the spirit of innovation within the pharmaceutical industry, making substantial contributions through his patents and collaborative efforts. His work not only showcases his inventiveness but also holds the potential to improve the quality of life for many suffering from debilitating conditions.